Teva Files Patent Infringement Complaints Regarding Sertraline ...
Business Wire (press release) - San Francisco,CA,USA
... Neurontin®, Wellbutrin XL® and the effects of competition on Copaxone® sales, including as a result of the reintroduction of Tysabri® into the market, ...
See all stories on this topic

Merck Serono begins MS oral therapy trial
Pharmaceutical Business Review Wed, 24 Jan 2007 6:03 PM PST
Merck Serono has begun a phase II study that will evaluate two dose regimens of its oral formulation of cladribine when added to a new formulation of Rebif in multiple sclerosis patients.
Researchers propose reason for severe side-effects of Northwick Park clinical trial
EurekAlert! Thu, 25 Jan 2007 6:17 AM PST
A possible reason why the Northwick Park clinical trial of the drug TGN1412 in the UK caused multiple organ failure in human volunteers is revealed in research presented today at a conference near Paris.

Trigeminal neuralgia may be cause of facial pain
The Biloxi Sun Herald Thu, 25 Jan 2007 1:07 AM PST
Dear Dr. Sangani: For the past few months, I have been experiencing severe pain in my jaw area that usually only lasts a few minutes. It does not happen when I eat. It happens at anytime. What could be causing this?

Chopping off protein puts immune cells into high gear
EurekAlert! Wed, 24 Jan 2007 2:17 PM PST
The complex task of launching a well-organized, effective immune system attack on specific targets is thrown into high gear when either of two specific enzymes chop a protein called LAG-3 off the immune cells leading that battle, according to investigators at St. Jude Children's Research Hospital.

Medical cannabis is a blunt tool New Scientist Wed, 24 Jan 2007 11:15 AM PST Results of clinical trials of cannabis have been mixed and it now seems there are fundamental problems with how our bodies respond to the stuff

The illness: Expensive insurance for serious health problems
Independent Weekly Wed, 24 Jan 2007 1:05 PM PST
The cure: Diving into the high-risk pool